Tower Research Capital LLC (Trc) Hille Vax, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hille Vax, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,692 shares of HLVX stock, worth $10,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,692
Previous 5,145
10.63%
Holding current value
$10,245
Previous $74,000
86.49%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.8MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.1 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$8.86 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.76 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.52 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.39 Million0.06% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $60.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.